Profil

Lifrange Eric

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Jerusalem, Guy  (25)
Coucke, Philippe  (20)
Colin, Claude  (14)
Desreux, Joëlle  (13)
Bleret, Valérie  (12)
Main Referenced Keywords
Humans (13); breast cancer (12); Female (12); Breast cancer (10); cancer du sein (8);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (2)
Giga-Genetics - ULiège (1)
Main Referenced Disciplines
Radiology, nuclear medicine & imaging (30)
Oncology (29)
Endocrinology, metabolism & nutrition (21)
Reproductive medicine (gynecology, andrology, obstetrics) (11)
Immunology & infectious disease (5)

Publications (total 82)

The most downloaded
2109 downloads
BOUS, A., NARDELLA, D., MAWEJA, S., LIFRANGE, E., & NIZET, J.-L. (2011). La chirurgie oncoplastique du sein. Revue Médicale de Liège, 66 (5-6), 341-50. https://hdl.handle.net/2268/113155

The most cited

93 citations (Scopus®)

Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcene, A., BIANCHI, E., GOFFLOT, S., Drion, P., Trombino, G. E., Di Valentin, E., CUSUMANO, G., MAWEJA, S., JERUSALEM, G., Delvenne, P., LIFRANGE, E., Castronovo, V., & Turtoi, A. (2015). Asporin Is a Fibroblast-Derived TGF-beta1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Medicine, 12 (9), 1001871. doi:10.1371/journal.pmed.1001871 https://hdl.handle.net/2268/192547

Danthine, D., Milicevic, M., & Lifrange, E. (October 2022). Une atteinte de la plaque aréolo-mamelonnaire. Revue Médicale de Liège, 77 (10), 603-608.
Editorial Reviewed verified by ORBi

Bleret, V., Cusumano, P., Danthine, D., Desreux, J., HOUET, E., REMACLE, N., & Lifrange, E. (May 2021). Cancer du sein : évaluation individualisée du risque en vue d’un dépistage sur mesure. Revue Médicale de Liège, 76 (5-6), 502 - 506.
Editorial Reviewed verified by ORBi

Jossa, V., Olivier, F., LIFRANGE, E., Crevecoeur, A., COURTOIS, A., Coibion, M., & JERUSALEM, G. (2021). From modified radical mastectomy to infra-radical mastectomy: A phase I study for surgical de-escalation focusing on pathological analyses. Gland Surgery. doi:10.21037/gs-21-48
Peer Reviewed verified by ORBi

Leclerc, A.-F., Foidart-Dessalle, M., Tomasella, M., Coucke, P., DEVOS, M., Bruyère, O., Bury, T., Deflandre, D., Jerusalem, G., LIFRANGE, E., KAUX, J.-F., Crielaard, J.-M., & Maquet, D. (October 2017). Multidisciplinary rehabilitation program after breast cancer: benefits on physical function, anthropometry and quality of life. European Journal of Physical and Rehabilitation Medicine, 53 (5), 633-642. doi:10.23736/S1973-9087.17.04551-8
Peer Reviewed verified by ORBi

Leclerc, A.-F., KAUX, J.-F., Crielaard, J.-M., Foidart-Dessalle, M., BURY, T., Deflandre, D., COUCKE, P., LIFRANGE, E., DEVOS, M., JERUSALEM, G., & Maquet, D. (18 July 2017). Influence of a multidisciplinary post-breast cancer rehabilitation program on lifestyle and behavior faced with physical activities [Poster presentation]. 19th Euro Congress on Cancer Science and Therapy, Lisbonne, Portugal.

BRAGARD, I., Etienne, A.-M., Faymonville, M.-E., Coucke, P., LIFRANGE, E., SCHROEDER, H., Wagener, A., Dupuis, G., & Jerusalem, G. (2017). A non-randomized comparison study of self-hypnosis, yoga and cognitive behavioral therapy to reduce emotional distress in breast cancer patients. International Journal of Clinical and Experimental Hypnosis, 65 (2), 189-209. doi:10.1080/00207144.2017.1276363
Peer Reviewed verified by ORBi

Blomme, A., Costanza, B., De Tullio, P., Thiry, M., Van Simaeys, G., Boutry, S., Doumont, G., Di Valentin, E., Hirano, T., Yokobori, T., GOFFLOT, S., Peulen, O., Bellahcene, A., Sherer, F., Le Goff, C., Cavalier, E., Mouithys-Mickalad, A., Jouret, F., CUSUMANO, G., ... Turtoi, A. (2016). Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer. Oncogene. doi:10.1038/onc.2016.369
Peer Reviewed verified by ORBi

Leclerc, A.-F., Foidart-Dessalle, M., BURY, T., Deflandre, D., COUCKE, P., JERUSALEM, G., LIFRANGE, E., DEVOS, M., CRIELAARD, J.-M., & Maquet, D. (2016). Influence d'un programme de revalidation multidisciplinaire post-cancer du sein sur la fonction physique. In 9ème Congrès commun SFMES - SFTS : Abstract book (pp. 43).

Bragard, I., Etienne, A.-M., Faymonville, M.-E., Coucke, P., DEVOS, M., LIFRANGE, E., SCHROEDER, H., Wagener, A., & Jerusalem, G. (2016). Etude pilote auprès de patientes atteintes d'un cancer du sein: Apport des méthodes alternatives. In A.-M. Etienne & I. Bragard, Evolutions Sociales, Innovations et Politiques: nouvelles questions et nouveaux enjeux pour la psychologie de la santé (pp. 51-54). Lyon, France: Editions des Archives Contemporaines.
Peer reviewed

Freres, P.* , Wenric, S.* , BOUKERROUCHA, M., Fasquelle, C., Thiry, J., Bovy, N., Struman, I., Geurts, P., COLLIGNON, J., SCHROEDER, H., KRIDELKA, F., LIFRANGE, E., Jossa, V., Bours, V.* , Josse, C.* , & JERUSALEM, G.*. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. doi:10.18632/oncotarget.6786
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Leclerc, A.-F., FOIDART-DESSALLE, M., Bury, T., Deflandre, D., COUCKE, P., JERUSALEM, G., LIFRANGE, E., DEVOS, M., CRIELAARD, J.-M., & Maquet, D. (2015). Psychological benefits of a multidisciplinary rehabilitation program after breast cancer. In European Cancer Congress : Abstract book.

Leclerc, A.-F., FOIDART-DESSALLE, M., Bury, T., Deflandre, D., COUCKE, P., JERUSALEM, G., LIFRANGE, E., DEVOS, M., CRIELAARD, J.-M., & Maquet, D. (26 September 2015). Physical benefits of a multidisciplinary rehabilitation program after breast cancer [Poster presentation]. European Cancer Congress, Vienne, Austria.

Mairiaux, P., Schippers, N., DESREUX, J., & LIFRANGE, E. (23 April 2015). Retour au travail après un cancer du sein [Paper presentation]. Les Jeudis de la Santé au Travail, Liège, Belgium.

NIZET, J.-L., MAWEJA, S., LAKOSI, F., LIFRANGE, E., SCAGNOL, I., SEIDEL, L., Albert, A., & JERUSALEM, G. (February 2015). Oncological and surgical outcome after oncoplastic breast surgery. Acta Chirurgica Belgica, 115, 33-41. doi:10.1080/00015458.2015.11681064
Peer Reviewed verified by ORBi

Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez-Palacios, A., Mouithys-Mickalad, A., LIFRANGE, E., Delvenne, P., Castronovo, V., & Turtoi, A. (31 January 2015). Myoferlin Regulates Endosomal Trafficking and Tunes Cancer Cell Metabolism [Poster presentation]. ASSOCIATION BELGE POUR L'ETUDE DU CANCER "A.B.E.C» ANNUAL MEETING 2015: TUMOR METABOLISM AND MITOCHONDRIA, Louvain, Belgium.

Blomme, A., Costanza, B., Thiry, M., De Tullio, P., Perez Palacios, A., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (27 January 2015). Myoferlin regulates endosomal trafficking and tunes cancer cell metabolism [Poster presentation]. GIGA-DAY 2015: Current advances in medical genetics and genomics, Liège, Belgium.

Slomian, J., LECLERC, A.-F., Maquet, D., JERUSALEM, G., LIFRANGE, E., COUCKE, P., Bury, T., TOMASELLA, M., Reginster, J.-Y., Bruyère, O., & Crielaard, J.-M. (2015). Prevalence of endocrine therapies that could affect bone health in women following a rehabilitation program after surgery for breast cancer. Osteoporosis International, 26 (S1), 375.
Peer Reviewed verified by ORBi

Maris, P., Blomme, A., Palacios, A. P., Costanza, B., Bellahcene, A., BIANCHI, E., GOFFLOT, S., Drion, P., Trombino, G. E., Di Valentin, E., CUSUMANO, G., MAWEJA, S., JERUSALEM, G., Delvenne, P., LIFRANGE, E., Castronovo, V., & Turtoi, A. (2015). Asporin Is a Fibroblast-Derived TGF-beta1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Medicine, 12 (9), 1001871. doi:10.1371/journal.pmed.1001871
Peer Reviewed verified by ORBi

REMACLE, S., LIFRANGE, E., & NIZET, J.-L. (January 2015). Prise en charge d'un cancer du sein chez une femme porteuse de prothèses mammaires. Revue Médicale de Liège, 70, 32-36.
Peer reviewed

Bragard, I., Etienne, A.-M., Faymonville, M.-E., Coucke, P., DEVOS, M., LIFRANGE, E., SCHROEDER, H., Wagener, A., Coudert, S., & Jerusalem, G. (16 December 2014). Améliorer le bien-être des patientes atteintes d’un cancer du sein par l’auto-hypnose, le yoga ou la TCC en groupe : faisabilité et premiers résultats au CHU de Liège [Paper presentation]. 8e congrès de l’Association Francophone de Psychologie de la Santé (AFPSA).

Cusumano, P. G., Generali, D., Ciruelos, E., Manso, L., Ghanem, I., LIFRANGE, E., Jerusalem, G., Klaase, J., de Snoo, F., Stork-Sloots, L., Dekker-Vroling, L., & Lutke Holzik, M. (2014). European inter-institutional impact study of MammaPrint. Breast, 23 (4), 423-8. doi:10.1016/j.breast.2014.02.011
Peer reviewed

Bragard, I., Etienne, A.-M., Faymonville, M.-E., Coucke, P., DEVOS, M., LIFRANGE, E., SCHROEDER, H., Wagener, A., & Jerusalem, G. (2014). Self-hypnosis, yoga or CBT group to face breast cancer: feasibility study and first results in Belgium. Psycho-oncology, 23 (suppl 3), 174.
Peer Reviewed verified by ORBi

Costanza, B., Blomme, A., Bellahcene, A., Hennequière, V., LIFRANGE, E., DELVENNE, P., Castronovo, V., & Turtoi, A. (2014). Myoferlin is a Key Regulator of HER Receptor Family Function in Breast Cancer [Paper presentation]. EDT Annual Mini symposium 2014.

Turtoi, A.* , Blomme, A.* , Bellahcene, A., Gilles, C., Hennequière, V., Peixoto, P., BIANCHI, E., Noël, A., De Pauw, E., LIFRANGE, E., Delvenne, P., & Castronovo, V. (2013). Myoferlin is a key regulator of EGFR activity in breast cancer. Cancer Research, 73, 5438-5448. doi:10.1158/0008-5472.CAN-13-1142
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

CUSUMANO, G., Generali, D., Ciruelos, E., Manso, L., Ghanem, I., LIFRANGE, E., JERUSALEM, G., Klaase, J., Stork-Sloots, L., & Lutke Holzik, M. (2012). European inter-institutional impact study of MammaPrint [Poster presentation]. ESMO 2012 Congress Vienna, Vienna, Austria.

DELCOMINETTE, S., CHANTRAINE, F., LIFRANGE, E., Defrère, P., Jacquy, C., Jost, E., & NISOLLE, M. (2012). Burkitt's breast lymphoma in pregnancy:ultrasound diagnosis and guided biopsy [Poster presentation]. ISUOG, Denmark.

DESREUX, J., BLERET, V., & LIFRANGE, E. (2012). Should we individualize breast cancer screening? Maturitas, 73, 202-205. doi:10.1016/j.maturitas.2012.08.004
Peer Reviewed verified by ORBi

Turtoi, A., Dumont, B., Greffe, Y., Blomme, A., Mazzucchelli, G., Delvenne, P., MUTIJIMA NZARAMBA, E., LIFRANGE, E., De Pauw, E., & Castronovo, V. (01 July 2011). Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues. Journal of Proteome Research, 10 (7), 3160-82. doi:10.1021/pr200212r
Peer Reviewed verified by ORBi

LAMBERT, C., Colin, Delvenne, P., & LIFRANGE, E. (May 2011). Techniques de prélèvements cytologiques en pathologie mammaire. Revue Médicale de Liège, 66 (5-6), 261-4.
Peer reviewed

COUCKE, P., JANSEN, N., JANVARY, Z. L., LOUIS, C., VANDERICK, J., RORIVE, A., COLLIGNON, J., LIFRANGE, E., MAWEJA, S., & JERUSALEM, G. (2011). Accelerated partial breast irradiation: state of the art. Belgian Journal of Medical Oncology, 5 (1), 3-7.
Peer Reviewed verified by ORBi

MARTIN, M., COLLIGNON, J., RORIVE, A., ANDRE, C., BOURHABA, M., ALLEPAERTS, S., COUCKE, P., LIFRANGE, E., & JERUSALEM, G. (2011). Le cancer du sein de la femme âgée. Revue Médicale de Liège, 66 (5-6), 400-408.
Peer reviewed

COLLIGNON, J., RORIVE, A., MARTIN, M., ANDRE, C., MAWEJA, S., LIFRANGE, E., COUCKE, P., & JERUSALEM, G. (2011). Chimiothérapie et cancer du sein. Revue Médicale de Liège, 66 (5-6), 372-378.
Peer reviewed

CUSUMANO, G., & LIFRANGE, E. (2011). The cancer screening controversy. European Journal of Cancer Prevention, Suppl 1 (S1). doi:10.1097/01.cej.0000391664.81996.b0
Peer Reviewed verified by ORBi

ANDRE, C., COLLIGNON, J., RORIVE, A., MARTIN, M., MAWEJA, S., LIFRANGE, E., COUCKE, P., & JERUSALEM, G. (2011). Le cancer du sein chez la femme jeune. Revue Médicale de Liège, 66 (5-6), 397-399.
Peer reviewed

NARDELLA, D., LAUNGANI, A., LIFRANGE, E., COUCKE, P., & NIZET, J.-L. (2011). Reconstruction mammaire immédiate et radiothérapie post-opératoire : une mise au point. Revue Médicale de Liège, 66 (5-6), 368-361.
Peer reviewed

BOUS, A., NARDELLA, D., MAWEJA, S., LIFRANGE, E., & NIZET, J.-L. (2011). La chirurgie oncoplastique du sein. Revue Médicale de Liège, 66 (5-6), 341-50.
Peer reviewed

JERUSALEM, G., COLLIGNON, J., RORIVE, A., LIFRANGE, E., ANDRE, C., MARTIN, M., MAWEJA, S., & COUCKE, P. (2011). Traitements ciblés dans le cancer du sein. Revue Médicale de Liège, 66 (5-6), 379-384.
Peer reviewed

BLERET, V., PINTIAUX, A., BELIARD, A., Kridelka, F., LIFRANGE, E., Van Cauwenberge, J.-R., & DESREUX, J. (2011). Prise en charge des consequences de la carence oestrogenique apres cancer du sein. Revue Médicale de Liège, 66 (5-6), 385-92.
Peer reviewed

DESREUX, J., Gaspard, U., BLERET, V., Van Cauwenberge, J.-R., THILLE, A., HERMAN, P., & LIFRANGE, E. (2011). Le cancer du sein en Belgique: pourquoi sommes-nous les premiers en Europe? Revue Médicale de Liège, 66 (5-6), 231-7.
Peer reviewed

Cusumano, P., BLERET, V., Nos, C., Hustinx, R., LILET, H., Gomez, P., & LIFRANGE, E. (2011). Ganglion sentinelle et sentibras: pour un "staging" axillaire sur mesure. Revue Médicale de Liège, 66 (5-6), 336-40.
Peer reviewed

BLERET, V., DESREUX, J., Cusumano, P., HERMAN, P., Kridelka, F., REMACLE, N., THILLE, A., & LIFRANGE, E. (2011). Prevention primaire et secondaire chez les femmes a haut risque de cancer mammaire. Revue Médicale de Liège, 66 (5-6), 245-9.
Peer reviewed

LIFRANGE, E., ANDRE, C., BLERET, V., BRADFER, J., CRISTINELLI, S., COUCKE, P., CUSUMANO, G., FRIDMAN, V., JERUSALEM, G., MARION, F., & COLIN, C. (2011). Prise en charge et suivi d'une série consécutive de 411 patientes opérées pour cancer du sein. Revue Médicale de Liège, 66 (5-6), 329-335.
Peer reviewed

BLERET, V., Cusumano, P., DEZFOULIAN, B., NARDELLA, D., Nizet, J.-L., Van Cauwenberge, J.-R., & LIFRANGE, E. (2011). Mastectomie bilaterale prophylactique chez les patientes a tres haut risque de cancer mammaire: au-dela de la technique. Revue Médicale de Liège, 66 (5-6), 250-3.
Peer reviewed

LIFRANGE, E., ANDRE, C., BLERET, V., COLLIGNON, J., COUCKE, P., CUSUMANO, G., DESREUX, J., HERMAN, P., JERUSALEM, G., KRIDELKA, F., MARTIN, M., RORIVE, A., Van Cauwenberge, J.-R., & COLIN, C. (2011). Hormonothérapie du cancer du sein. Revue Médicale de Liège, 66 (5-6), 367-371.
Peer reviewed

Bleret, V., Collignon, J., Coucke, P., Cusumano, G., DESREUX, J., Herman, P., Jerusalem, G., Maweja, S., Remacle, N., Rorive, A., & Lifrange, E. (2010). L'observance au traitement de longue durée : le cas particulier de l'hormonothérapie adjuvante du cancer du sein. Revue Médicale de Liège, 65 (5-6), 405-408.
Peer reviewed

Collignon, J., Gennigens, C., Rorive, A., Coucke, P., Lifrange, E., Maweja, S., Fillet, G., & Jerusalem, G. (May 2009). ANTICORPS MONOCLONAUX ET CANCER DU SEIN: Actualités thérapeutiques. Revue Médicale de Liège, 64 (5-6), 279-83.
Peer reviewed

Bleret, V., Lifrange, E., Ghuysen, V., Milet, J., Fridman, V., & Colin, C. (January 2008). Validation de la technique de biopsie du ganglion sentinelle dans le cancer du sein. Revue Médicale de Liège, 63 (1), 37-42.
Peer reviewed

HERMAN, P., Lifrange, E., Nisolle, M., Kridelka, F., Nervo, P., & Gaspard, U. (2007). Actualites therapeutiques en gynecologie: pathologies organiques. Revue Médicale de Liège, 62 (5-6, May-Jun), 414-22.
Peer reviewed

BUDZAR, A., CHLEBOWSKI, R., CUZICK, J., DUFFY, S., FORBES, J., JONAT, W., RAVDIN, P., & LIFRANGE, E. (2006). Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer. Current Medical Research and Opinion, 22, 1575-1585.
Peer Reviewed verified by ORBi

Lifrange, E., Bleret, V., Desreux, J., Dondelinger, R., Foidart, J.-M., Gaspard, U., Herman, P., Van Cauwenberge, J.-R., & Colin, C. (May 2003). Interet et limites du depistage de masse du cancer du sein par mammographie seule (mammotest). Revue Médicale de Liège, 58 (5), 331-7.
Peer reviewed

van den Brule, F., Lifrange, E., Pintiaux, A., Foidart, J.-M., & Gaspard, U. (April 2003). Hormonosubstitution postmenopausique et risque de cancer mammaire: une mise a jour. Revue Médicale de Liège, 58 (4), 254-60.
Peer reviewed

Foidart, J.-M., Desreux, J., Lifrange, E., & Colin, C. (February 2003). Traitement hormonal apres cancer du sein. Oui ... ou non? Revue Médicale de Liège, 58 (2), 77-82.
Peer reviewed

Lifrange, E., Dondelinger, R., Foidart, J.-M., Bradfer, J., Quatresooz, P., & Colin, C. (December 2002). Percutaneous stereotactic en bloc excision of nonpalpable breast carcinoma: a step in the direction of supraconservative surgery. Breast, 11 (6), 501-508. doi:10.1054/brst.2002.0464
Peer reviewed

Lifrange, E., Dondelinger, R., Quatresooz, P., Vandevorst, G., & Colin, C. (September 2002). Stereotactic breast biopsy with an 8-gauge, directional, vacuum-assisted probe: initial experience. European Radiology, 12 (9), 2180-2187. doi:10.1007/s00330-002-1382-6
Peer Reviewed verified by ORBi

Lifrange, E., Dondelinger, R. F., Fridman, V., & Colin, C. (2001). En Bloc Excision of Nonpalpable Breast Lesions Using the Advanced Breast Biopsy Instrumentation System: An Alternative to Needle Guided Surgery? European Radiology, 11 (5), 796-801. doi:10.1007/s003300000736
Peer Reviewed verified by ORBi

Lifrange, E., & Colin, C. (May 2000). La chirurgie mammaire supraconservatrice. Journal de Gynécologie, Obstétrique et Biologie de la Reproduction, 29 (3), 285-7.
Peer Reviewed verified by ORBi

LIFRANGE, E., BOURDOUX, B., DONDELINGER, R., Foidart, J.-M., FRIDMAN, V., GASPARD, U., HERMAN, P., DESREUX, J., Van Cauwenberge, J.-R., VENNEMAN, I., & COLIN, C. (2000). Prise en charge diagnostique et thérapeutique d'une opacité suspecte par la méthode ABBI. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 5, 14-15.
Peer reviewed

Lifrange, E., & Colin, C. (May 1999). Les faces cachées du cancer du sein: modalites du suivi des hyperplasies et des cancers in situ. Contraception, Fertilite, Sexualité, 27 (5), 364-7.
Peer Reviewed verified by ORBi

LIFRANGE, E., DONDELINGER, R., Foidart, J.-M., GASPARD, U., HERMAN, P., LAMBOTTE, R., DESREUX, J., Van Cauwenberge, J.-R., & COLIN, C. (1999). Apport des techniques nouvelles d'imagerie médicale en gynécologie : sénologie interventionnelle, possibilités diagnostiques et thérapeutiques. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 4, 54.
Peer reviewed

LIFRANGE, E., BOURDOUX, B., DESREUX, J., DONDELINGER, R., Foidart, J.-M., FRIDMAN, V., GASPARD, U., HERMAN, P., Van Cauwenberge, J.-R., VENNEMAN, I., & COLIN, C. (1999). Prise en charge diagnostique d'un amas de calcifications atypiques par la méthode MIBB. Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 4, 219-220.
Peer reviewed

Lifrange, E., & Colin, C. (December 1998). A propos des prothèses mammaires. L'examen senologique conventionnel. Revue Médicale de Liège, 53 (12), 746-9.
Peer reviewed

Foidart, J.-M., Colin, C., & Lifrange, E. (April 1998). A propos de la prévention du cancer du sein par le tamoxifene. Revue Médicale de Liège, 53 (4), 225-6.
Peer reviewed

Biquet, G., BRICHANT, J.-F., DEWANDRE, P.-Y., De Sart, F., Dubois, M., Foidart, J.-M., Garnir, D., Gaspard, U., Gillot, M., Hardy, A.-F., Herman, P., Jacobs, J. L., Laloux, F., Lifrange, E., Retz, C., Rigo, J., Sérilas, M., Schaaps, J.-P., Theunissen, I., ... Van den Brule, F. (March 1997). Attitudes obstétricales: Consensus de Département ULg. Document des cours de troisième cycle, octobre 96. Revue Médicale de Liège, 52 (3), 142-8.
Peer reviewed

Lifrange, E., & Colin, C. (February 1997). Vers une chirurgie "supraconservatrice" des lésions mammaires infracliniques? Revue Médicale de Liège, 52 (2), 72-6.
Peer reviewed

Lifrange, E., Kridelka, F., & Colin, C. (January 1997). Stereotaxic Needle-Core Biopsy and Fine-Needle Aspiration Biopsy in the Diagnosis of Nonpalpable Breast Lesions: Controversies and Future Prospects. European Journal of Radiology, 24 (1), 39-47. doi:10.1016/S0720-048X(96)01114-X
Peer Reviewed verified by ORBi

PETIT, J., RIETJENS, M., FERREIRA, M., MONTRUCOLI, D., LIFRANGE, E., & MARTINELLI, P. (1997). Abdominal sequelae after pedicled TRAM flap breast reconstruction. Plastic and Reconstructive Surgery, 99, 723-729. doi:10.1097/00006534-199703000-00019
Peer Reviewed verified by ORBi

LIFRANGE, E., & COLIN, C. (1997). Vers une chirurgie mammaire supraconservatrice des lésions mammaires infracliniques? Gunaïkeia. Société Royale Belge de Gynécologie et d'Obstétrique, 2, 65-66.
Peer reviewed

LIFRANGE, E., & COLIN, C. (1997). Prise en charge des lésions mammaires infracliniques : état de la question et perspectives nouvelles. Sein (Le), 7, 91-99.
Peer reviewed

COLIN, C., & LIFRANGE, E. (1994). Microbiopsies mammaires sous échographie. Sein (Le), 4, 145-147.
Peer reviewed

Colin, C., Lifrange, E., & Lambotte, R. (February 1993). Diagnostic des lésions mammaires non palpables: intérêt des biopsies à l'aiguille stéréoguidée. Revue Médicale de Liège, 48 (2), 113-20.
Peer reviewed

Lauricella-Lefèbvre, M. A., Piette, J., Lifrange, E., Lambotte, R., Gérard, P., & Rentier, B. (April 1992). High-rate of multiple genital HPV infections detected by DNA hybridization. Journal of Medical Virology, 36 (4), 265-270. doi:10.1002/jmv.1890360406
Peer Reviewed verified by ORBi

LIFRANGE, E., & COLIN, C. (1992). Diagnostic des lésions mammaires non palpables: contribution des biopsies à l’aiguille stéréoguidée (à propos de 148 cas). Sein (Le), 2, 68-75.
Peer reviewed

COLIN, C., EVRAUD, G., LIFRANGE, E., & BOOZ, G. (1992). Stereotactic fine-needle aspiration biopsy and percutaneous core-biopsy of solid nonpalpable breast lesions. JBR-BTR, (BTR 75), 1-6.
Peer reviewed

COLIN, C., LIFRANGE, E., EVRAUD, G., & CREVECOEUR, A. (1991). Qu'attendre de l'échographie mammaire? Contraception Fertilité Sexualité, 19 (n°4), 320-323.
Peer reviewed

Colin, C., Lifrange, E., Genicot, F., Castronovo, V., & Lambotte, R. (November 1990). Le tamoxifene comme premier traitement du cancer du sein chez la femme âgée: un recul de 10 ans. Revue Médicale de Liège, 45 (11), 533-8.
Peer reviewed

Lauricella, M.-A., Piette, J., Lifrange, E., Lambotte, R., & Rentier, B. (1990). Typing of human papillomaviruses in genital specimens by DNA hybridization. Archives Internationales de Physiologie et de Biochimie, 98 (2), 34.
Peer Reviewed verified by ORBi

Castronovo, V., Colin, C., Claysmith, A. P., Chen, P. H., Lifrange, E., Lambotte, R., Krutzsch, H., Liotta, L. A., & Sobel, M. E. (1990). Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. American Journal of Pathology, 137 (6), 1373-81.
Peer Reviewed verified by ORBi

Lauricella, M.-A., Piette, J., Lifrange, E., Lambotte, R., & Rentier, B. (1990). Typing of human papillomaviruses in belgian genital specimens with or without abnormal cervical cytology by DNA hybridization [Paper presentation]. Papillomavirus Workshop, Heidelberg, Germany.

Lifrange, E., Lauricella, M., Rentier, B., Piette, J., Binard, J. M., & Lambotte, R. (1989). Intérêt du typage viral des papillomavirus humains (HPV) en relation avec les neoplasies des muqueuses genitales. Revue Médicale de Liège, 44 (1), 1-14.
Peer reviewed

Lifrange, E., & Rentier, B. (1989). Diagnostic des infections génitales à Papillomavirus [Paper presentation]. 3èmes Journées Liégeoises de Gynécologie et d'Obstétrique, Liège, Belgium.

Reznik, M., LIFRANGE, E., MOUCHETTE, R., & EVRARD, P. (1987). Myélinolyse centrale du pont, son cadre nosographique parmi les lésions neuropathologiques dues à l'alcoolisme. Revue Médicale de Liège, 42, 285-291.
Peer reviewed

Gilis, F., Massart, B., LIFRANGE, E., Van Lancker, M. A., Jardon-Jeghers, C., Tjean, M., Bury, J., & Boniver, J. (1985). A propos d'un séminome médiastinal. Revue Médicale de Liège, 40 (11), 474-9.
Peer reviewed

Contact ORBi